Published in Cancer Res on February 01, 1992
Targeting of skeletal muscle in vitro using biotinylated immunoliposomes. Biochem J (2004) 0.84
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. Br J Cancer (1996) 0.84
Analysis of idiotope structure of ovarian cancer antibodies: recognition of the same epitope by two monoclonal antibodies differing mainly in their heavy chain variable sequences. Clin Exp Immunol (1994) 0.76
Serodiagnosis of Trichinella spiralis infections in pigs by enzyme-linked immunosorbent assays. Bull World Health Organ (1974) 2.59
Reliability of the enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of Trichinella spiralis infections in conventionally raised pigs. J Immunol Methods (1976) 2.09
Tumour-targeted nanomedicines: principles and practice. Br J Cancer (2008) 1.81
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet (1992) 1.74
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets (2009) 1.70
Direct measurement of microplates and its application to enzyme-linked immunosorbent assay. J Clin Microbiol (1976) 1.68
The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials (2010) 1.63
Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev (2001) 1.62
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther (2001) 1.55
The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas. Am J Clin Pathol (1994) 1.47
Letter: Application of ELISA--enzyme linked immunosorbent assay--in the sero-diagnosis of amoebiasis. Trans R Soc Trop Med Hyg (1975) 1.44
An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. J Control Release (2011) 1.43
Monoclonal antibody against human ovarian tumor-associated antigens. J Natl Cancer Inst (1986) 1.40
Intestinal phase of Trichinella spiralis in congenitally athymic (nude) mice. J Parasitol (1974) 1.37
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta (1997) 1.35
Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum (2000) 1.32
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther (2000) 1.32
Application of immunofluorescence and immunoenzyme methods in the serodiagnosis of Trichinella spiralis infection. Ann N Y Acad Sci (1975) 1.31
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis (1993) 1.30
Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. Clin Chem (1990) 1.28
Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids (1993) 1.24
Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects. Arch Environ Health (1999) 1.23
Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril (1991) 1.23
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer (2008) 1.23
Association between exhaled nitric oxide, ambient air pollution and respiratory health in school children. Int Arch Occup Environ Health (2002) 1.20
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res (1991) 1.17
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin. Cancer Immunol Immunother (1991) 1.16
Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett (1995) 1.16
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol Immunother (1992) 1.15
The athymic nude rat. III. Natural cell-mediated cytotoxicity. Clin Immunol Immunopathol (1980) 1.15
The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release (2000) 1.14
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta (1993) 1.14
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol (1998) 1.12
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res (2003) 1.11
Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J Gene Med (2004) 1.10
Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis (2004) 1.09
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther (2000) 1.08
Mechanization of the enzyme-linked immunosorbent assay (ELISA) for large scale screening of sera. J Immunol Methods (1977) 1.07
Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr (1982) 1.07
Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. Gastroenterology (1987) 1.06
Exhaled nitric oxide: a novel biomarker of adverse respiratory health effects in epidemiological studies. Arch Environ Health (2000) 1.06
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release (1998) 1.04
Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens. Int J Gynecol Pathol (1991) 1.04
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release (1999) 1.03
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother (2001) 1.03
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res (1987) 1.01
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res (1996) 1.01
The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins. Biochemistry (1993) 1.00
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. Biochim Biophys Acta (1995) 1.00
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J Nucl Med (1999) 0.99
Liposomes and ISCOMS as vaccine formulations. Biochim Biophys Acta (1995) 0.99
Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med (1995) 0.99
Marker profile of mesothelial cells versus ovarian carcinoma cells. Int J Cancer (1989) 0.98
In vivo applications of PEG liposomes: unexpected observations. Crit Rev Ther Drug Carrier Syst (2001) 0.98
Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm (2006) 0.98
Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach. Angiogenesis (2011) 0.98
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm (2001) 0.97
Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J Immunol (2000) 0.97
Optimization of poly(amido amine)s as vectors for siRNA delivery. J Control Release (2010) 0.97
Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. Biochim Biophys Acta (1999) 0.96
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med (2000) 0.96
On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim Biophys Acta (1991) 0.96
Micelles based on HPMA copolymers. Adv Drug Deliv Rev (2009) 0.96
Possible immunosuppressive effect of Corynebacterium parvum on infection with Trichinella spiralis. Nat New Biol (1973) 0.96
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. Int J Pharm (1999) 0.95
Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies. J Thromb Haemost (2007) 0.95
Characterization of a human ovarian carcinoma cell line, OTN 14, derived from a mucinous cystadenocarcinoma. Int J Cancer (1988) 0.95
Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue. Pharm Res (2001) 0.94
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes. Infect Immun (1986) 0.94
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta (1999) 0.94
The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target (1995) 0.94
Ozone-induced inflammation assessed in sputum and bronchial lavage fluid from asthmatics: a new noninvasive tool in epidemiologic studies on air pollution and asthma. Free Radic Biol Med (1999) 0.93
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim Biophys Acta (2001) 0.93
Retrograde seeding of endometrial epithelial cells by uterine-tubal flushing. Fertil Steril (1991) 0.92
Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochim Biophys Acta (1999) 0.92
Changes in expression of differentiation markers between normal ovarian cells and derived tumors. Am J Pathol (1993) 0.92
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release (2000) 0.92
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release (2003) 0.91
Schistosoma mansoni: comparison of the immunoperoxidase techniques, DASS and ELISA, for human diagnosis. Exp Parasitol (1977) 0.91
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J Nucl Med (1996) 0.91
Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol (1991) 0.91
Chemical hydrolysis of phospholipids. J Pharm Sci (1995) 0.90
Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol (2000) 0.90
Anodic coulometric detection with a glassy carbon electrode in combination with reversed-phase high-performance liquid chromatography. Determination of blood levels of perphenazine and fluphenazine. J Chromatogr (1976) 0.90
Plasmodium berghei: immunosuppression and hyperimmunoglobulinemia. Exp Parasitol (1977) 0.90
Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J Pharm Sci (1993) 0.89
Reduced expression of protein tyrosine phosphatase gamma in lung and ovarian tumors. Cancer Lett (1999) 0.88